GlassScriptPhysician profile
Norman Ray Clark
NPI 1487897997
$9,293.27
in general payments reported to CMS, 2019-2025
36 companies · $1,918 in 2025
The $1,918 reported for 2025 was more than what 78% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $918 · 2020: $597 · 2021: $1,208 · 2022: $1,741 · 2023: $1,373 · 2024: $1,538 · 2025: $1,918.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,751 · Education: $77.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,751.21 |
| Education | $77.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,660.23 | 2019-2025 | Skyrizi, Rinvoq, Linzess |
| Janssen Biotech, INC. | $1,065.71 | 2019-2025 | Tremfya, Stelara, Simponi Aria |
| Gilead Sciences, INC. | $771.55 | 2019-2025 | Livdelzi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $763.00 | 2019-2025 | Xifaxan, Trulance, Plenvu |
| Takeda Pharmaceuticals U.S.A., INC. | $677.21 | 2020-2025 | Entyvio, Gattex, Eohilia |
| Ironwood Pharmaceuticals, INC | $506.91 | 2019-2024 | Linzess |
| Medtronic USA, INC. | $227.40 | 2019-2020 | |
| Qol Medical, LLC | $191.48 | 2022-2025 | Sucraid, Sucraid |
| Pfizer INC. | $188.96 | 2019-2025 | |
| Phathom Pharmaceuticals, INC. | $185.68 | 2024-2025 | Voquezna |
| Intercept Pharmaceuticals, INC. | $184.46 | 2019-2024 | |
| Genzyme Corporation | $180.92 | 2022-2025 | |
| Axonics, INC. | $163.72 | 2021-2023 | Axonics |
| Nestle Healthcare Nutrition INC. | $161.35 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $150.00 | 2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Enterra Medical, INC. | $145.14 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $139.65 | 2022-2024 | Dupixent |
| Lucid Diagnostics INC. | $119.51 | 2021 | |
| Boston Scientific Corporation | $113.12 | 2022 | |
| Merck Sharp & Dohme LLC | $91.55 | 2019-2024 | Dificid |
| Ferring Pharmaceuticals INC. | $82.90 | 2022-2023 | Rebyota, Cimzia |
| Romark Laboratories, Lc | $65.86 | 2019-2020 | |
| Endogastric Solutions, INC | $62.57 | 2019 | |
| Madrigal Pharmaceuticals | $58.64 | 2025 | Rezdiffra |
| Daiichi Sankyo INC. | $58.63 | 2023-2024 | Injectafer |
| Lilly USA, LLC | $54.50 | 2024-2025 | Omvoh |
| Celltrion USA INC. | $46.84 | 2024 | Zymfentra |
| Celgene Corporation | $38.23 | 2021-2023 | Zeposia |
| Organon LLC | $34.67 | 2023-2024 | Renflexis |
| Ardelyx, INC. | $20.24 | 2025 | Ibsrela |
| Pentax of America, INC. | $19.29 | 2023 | N/A |
| Olympus America INC. | $14.18 | 2024 | Disposable Distal Attachment |
| Ucb, INC. | $14.15 | 2019 | |
| Fresenius Kabi USA, LLC | $12.72 | 2023 | Idacio |
| Intra-Sana Laboratories | $11.28 | 2021 | |
| Shionogi INC | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norman Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.